SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Canaccord Genuity Maintains Buy on Zimmer Biomet Holdings, Raises Price Target to $137

Canaccord Genuity maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Buy and raises the price target from $135 to $137.

Benzinga · 05/12/2020 16:21

Canaccord Genuity maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Buy and raises the price target from $135 to $137.